ARTICLE | Clinical News
InKine begins pivotal Colirest trial
June 25, 2001 7:00 AM UTC
InKine began (INKP) a pivotal multicenter, randomized, dose-ranging U.S. study of Colirest, an oral anti-inflammatory steroid for treatment of Crohn's disease. INKP plans to enroll 250 patients by the...